[1]
T. Konaka, M. Kawami, A. Yamamoto, R. Yumoto, and M. Takano, “miR-484: A Possible Indicator of Drug-Induced Pulmonary Fibrosis”, J Pharm Pharm Sci, vol. 23, pp. 486–495, Nov. 2020.